Expanding indications for RYONCIL in children and adults with life-threatening inflammatory diseases

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let'

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition propo

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

Mesoblast transitions to a commercial-stage company, anchored by FDA-approved Ryoncil and robust ear

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

Optimized capital structure, retiring short-term maturing debt Well-funded for commercial operations

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Repo

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

Stock News JPMorgan tops Q1 estimates: JPMorgan Chase (JPM) posted Q1 EPS of $5.94 on revenue of $50

Mesoblast Limited (NASDAQ: MESO - Get Free Report) Director Gregory George bought 1,981,890 shares o

Mesoblast Limited (NASDAQ: MESO - Get Free Report) Director Gregory George acquired 4,000,000 shares

Mesoblast Limited (NASDAQ: MESO - Get Free Report) Director Gregory George acquired 2,324,072 shares

Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification a

Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript

Mesoblast (MESO) is upgraded to a speculative Buy as Ryoncil outperforms in pediatric SR-aGVHD and a

Mesoblast outlines commercial strategy to double net revenues as Ryoncil ® approaches US$100M net re

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible

U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo

Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) rose sharply in pre-market trading after the co